tirzepatide vision loss macular degeneration NEJM Editorial Fellow Katerina Lin, MD, unpacks the science behind a study on tirzepatide vision changes Zepbound Blindness

The SUSTAIN 6 trial showed that subcutaneous semaglutide reduced major adverse cardiovascular events by 26% in patients with type 2 diabetes and established cardiovascular disease (hazard ratio 0.74, 95% CI 0.58-0.95)

Shortages are par for the course at this stage

Gastroparesis (stomach paralysis), which has been linked to Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, and Trulicity, causes constant and severe nausea and vomiting, abdominal pain, severe dehydration, acid reflux, malnutrition, and weight loss

10.1080/17425255.2018.1541981 27 ChangH

Avoid rapid thawing at high temperatures

The mechanism of action of semaglutide involves increasing sensitivity to insulin, which helps reduce overall circulating glucose and ultimately lowers the average blood sugar level